Acamprosate versus Naltrexone for Alcohol Dependence

Efficacy Comparison

• The American Association for the Study of Liver Diseases recommends acamprosate as the preferred choice in patients with liver disease due to its lack of hepatic metabolism, while naltrexone may be slightly more effective at preventing return to any drinking in patients without hepatic concerns 1
• Naltrexone demonstrates superior efficacy in reducing cue-induced craving and preventing return to any drinking, with a number needed to treat (NNT) of approximately 20 compared to acamprosate's NNT of 12 1
• Acamprosate is more effective at maintaining continuous abstinence once achieved, reducing drinking frequency and decreasing the severity of relapse when it occurs, as recommended by the American College of Physicians 2

Critical Clinical Decision Points

• In patients with alcohol-associated liver disease (ALD), acamprosate is strongly preferred because it undergoes no hepatic metabolism and has no reported instances of hepatotoxicity, according to the American Association for the Study of Liver Diseases 1
• Naltrexone undergoes hepatic metabolism and carries hepatotoxicity concerns, making it contraindicated or requiring extreme caution in ALD patients, as noted by the American Association for the Study of Liver Diseases 1
• The World Health Organization guidelines recommend choosing between these medications based on patient preferences, motivation, and availability rather than routinely combining them 4, 5

Practical Implementation

• The American College of Physicians recommends that acamprosate must be started 3-7 days after last alcohol consumption and only after withdrawal symptoms have resolved, not immediately after sobering up 2
• Standard dosing of acamprosate is 666 mg (two 333 mg tablets) three times daily for patients ≥60 kg, as recommended by the American Association for the Study of Liver Diseases 1
• The American Association for the Study of Liver Diseases recommends that treatment duration for acamprosate is 3-6 months minimum, can extend to 12 months 2

Common Pitfalls to Avoid

• Starting acamprosate too early (before complete detoxification) reduces efficacy since its mechanism is maintaining rather than inducing abstinence, as noted by the American College of Physicians 2
• Failing to combine either medication with comprehensive psychosocial treatment is not recommended, according to the American Association for the Study of Liver Diseases and the World Health Organization 1, 5